April 29, 2026

Molecular research: When speed meets precision

Molecular research: When speed meets precision

KIMMDY software visualizes biological processes in motion – conceived and originally developed at HITS, refined and published at the Max Planck Institute for Polymer Research in Mainz

Within biological cells, molecules are constantly in motion. Investigating these motions, however, is still difficult, due to the fact that these processes occur on very small length and time scales. To overcome these challenges, researchers from the Heidelberg Institute for Theoretical Studies (HITS) and the Max Planck Institute for Polymer Research (MPIP) have developed a simulation method that works rapidly and can predict chemical processes in cells with high precision. Their findings have been published in Nature Communications.

Beyond the limits of standard computer simulations

Using a new method based on artificial intelligence, researchers can now simulate complex molecular reactions while also accounting for changes in chemical bonds (Pictures. MPIP)

For years, researchers have been using computer simulations to study the behavior of molecules. But these simulations lack one key feature of life: reactivity, which has to be sacrificed for efficiency. Standard methods can handle large systems at sufficient timescales, but bonds cannot break and form in these models. Monitoring the interplay of molecular motion and chemical events, however, is crucial to understanding and designing complex molecular systems.

Researchers from HITS and MPIP have developed a method to overcome this limitation. The new software KIMMDY (short for: Kinetic Monte Carlo Molecular Dynamics) combines various computational approaches and uses machine learning methods to calculate when and where chemical reactions can occur.

“This allows us not only to track how molecules move, but also how they react with one another,” says Frauke Gräter, director of the “Biomolecular Mechanics” department at MPIP and former group leader at HITS. “This, in turn, opens up entirely new possibilities for investigating complex biological processes on a computer.”

The newly developed method makes it possible to simulate very large molecular systems—such as proteins or DNA in their natural environment—while also tracking reaction chains in which one chemical step triggers the next. Such processes play a role in many biological contexts, e.g. in collagen, a protein crucial for the stability of our skin, bones, and connective tissue. The research team was able to track how reactive molecular fragments migrate through the protein and accumulate at specific sites. Damage to DNA, such as that caused by UV radiation, can now also be investigated. 

This new method stands out because it allows systems with millions of atoms to be calculated more efficiently than in competing approaches. This means that KIMMDY could help us better understand biological and chemical processes in the future. At the same time, KIMMDY opens up new possibilities for interpreting experimental results and planning new experiments. The project was supported by the Klaus Tschira Foundation.

Publication:
Hartmann, E.; Buhr, J.; Riedmiller, K.; Ulanov, E.; Schüpp, B.; Kiesewetter, D.; Sucerquia, D.; Aponte-Santamaría, C.; Gräter, F. KIMMDY: a biomolecular reaction emulator. Nat Commun 17, 3500 (2026) Source DOI

More information: www.simplaix.org

Scientific contact:
Prof. Dr. Frauke Gräter
Director
Max Planck Institute for Polymer Research
graeter@mpip-mainz.mpg.de

Press contact:
Angela Michel
Head of Communications
Heidelberg Institute for Theoretical Studies (HITS)
E-Mail: angela.michel@h-its.org
www.h-its.org

Our latest News

discover more
A Vaccine for Parkinson’s?

A Vaccine for Parkinson’s?

The Parkinson Foundation has awarded three Innovation Prizes for 2026, including—for the first time—the Manfred Moggert-Kemper Prevention Prize. Prof. Dr. Chi Wang Ip and Assistant Professor Dr. Rhonda McFleder from the Department of Neurology at the University Hospital of Würzburg (UKW), as well as Prof. Dr. Mathias Munschauer from the University Hospital of Heidelberg (UKHD), […]

Study from Heidelberg: Does Targeted Preparation Help with Recovery After Colon Cancer Surgery?

Study from Heidelberg: Does Targeted Preparation Help with Recovery After Colon Cancer Surgery?

Do patients recover more quickly after colorectal cancer surgery if they have previously completed a structured preparatory program? Researchers at Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital are investigating this question in the newly launched PREHAB-PEER study. The Federal Ministry of Research, Technology, and Space is funding the project with approximately 3.45 million […]

Building Better Sandwich Immunoassays: A Toolbox for Biopharma Development Teams

Building Better Sandwich Immunoassays: A Toolbox for Biopharma Development Teams

Immunoassay development used to just mean getting a classic plate-based ELISA up and running. Today, that “standard” ELISA has exploded into many antibody pair-based formats, from homogeneous TR‑FRET assays to multiplexed MSD or Luminex panels—each with its own advantages and pitfalls. The data these assays generate is more robust than ever, but so is the […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp